Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CDK2 translational down-regulation during endothelial senescence.

Deborah A Freedman1, Judah Folkman

  • 1Vascular Biology Program, Department of Surgery, Children's Hospital, 1 Blackfan Circle, Harvard University Medical School, Karp Family Research Laboratories, Floor 12, Boston, MA 02115, USA.

Experimental Cell Research
|June 1, 2005
PubMed
Summary

Loss of CDK2 activity, due to translational decline and p21 inhibition, drives endothelial cell senescence. Telomerase bypasses senescence by restoring CDK2 translation and activity, revealing a key regulatory mechanism.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of lymphatic malformations using primary cells and tissue transcriptomes.

Scandinavian journal of immunology·2019
Same author

Spontaneous reversion of the angiogenic phenotype to a nonangiogenic and dormant state in human tumors.

Molecular cancer research : MCR·2014
Same author

Inhibition of EGF signaling protects the diabetic retina from insulin-induced vascular leakage.

The American journal of pathology·2013
Same author

Inhibition of tumor angiogenesis by oral etoposide.

Experimental and therapeutic medicine·2012
Same author

Consensus micro RNAs governing the switch of dormant tumors to the fast-growing angiogenic phenotype.

PloS one·2012
Same author

Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer.

Proceedings of the National Academy of Sciences of the United States of America·2012

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Gerontology

Background:

  • Endothelial cell senescence limits cellular lifespan and impacts tissue function.
  • Cyclin-dependent kinase 2 (CDK2) activity is crucial for cell cycle progression.

Purpose of the Study:

  • To investigate the role of CDK2 activity and its regulators in endothelial cell senescence.
  • To explore mechanisms by which endothelial cells bypass senescence.

Main Methods:

  • Utilized dominant-negative p53 expression and telomerase introduction in human umbilical vein endothelial cells (HUVECs).
  • Analyzed expression of cell-cycle inhibitors (p16INK4a, p21Cip1/Waf1) and CDK2 protein levels and activity.
  • Assessed CDK2 translation rates and protein stability during senescence and immortalization.

Related Experiment Videos

Main Results:

  • Loss of CDK2 activity, via translational inhibition and p21Cip1/Waf1, is linked to endothelial senescence.
  • Telomerase expression in HUVECs leads to immortalization (i-HUVECs) by restoring CDK2 translation and activity.
  • Senescent HUVECs exhibit undetectable CDK2 activity due to reduced protein levels and p21 inhibition; p16INK4a expression persists.

Conclusions:

  • CDK2 translational down-regulation is a key event in endothelial replicative senescence.
  • p16INK4a does not appear to play a significant role in endothelial senescence.
  • Understanding endothelial senescence mechanisms is vital for cancer research.